FTC sues significant pharmacy gain administrators about insulin charges The agency brought motion in opposition to Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating methods “artificially inflated” the record cost of life-preserving insulin medicines. Listen to the posting 10 min This audio is automobile-produced. Be sure https://labelthefigurewiththeitem73727.tribunablog.com/the-smart-trick-of-healthcare-news-that-no-one-is-discussing-45047549